CMCT trades on the Nasdaq Capital Market with a market capitalization of roughly $10 million and about 3.2 million shares outstanding, placing it firmly in the micro-cap category. That small size magnifies price movement: the shares have ranged from $1.78 to a split-adjusted 52-week high of $1,441, and a beta near 1.09 indicates greater-than-market volatility.
Over the trailing 30 days, the stock has been turbulent rather than trending in one direction. A 52.6% surge on Sept. 30 carried the shares from $1.92 to $2.93 on heavy turnover, followed by a climb toward the $3.89 level and then a 17.2% pullback to $3.22 on Oct. 29. The net result is a modest gain of about 9.9% over the period, masking the violent intraday swings beneath the surface. On a longer horizon, the shares have drifted lower from the $4–5 range seen in August, reflecting continued investor caution.
CMCT is a Maryland-incorporated real estate investment trust (REIT) that owns, operates, and develops creative office and premier multifamily properties across the United States, along with one hotel in Northern California. Its creative office portfolio targets tenants in technology, media, and entertainment, while its multifamily holdings are concentrated in urban markets with comparable employment and demographic characteristics. The company is externally managed by affiliates of CIM Group, L.P., a vertically integrated owner and operator of real assets, which supplies acquisition, development, financing, leasing, and property-management expertise.
Investors follow CMCT primarily for its repositioning story rather than for income: the company suspended its common dividend, and its competitive position is shaped by the premium creative-office niche and a push toward multifamily assets. Its small equity base, ongoing losses, and reliance on preferred-stock redemptions make balance-sheet execution the central risk and opportunity for shareholders.
Several verified developments have shaped sentiment over the past month. On Sept. 29, the company declared third-quarter preferred stock dividends on its Series A, Series A1, and Series D shares. The following session produced a 52.6% advance on more than 32 million shares changing hands—turnover far above the stock's typical daily volume—underscoring how thin trading conditions can drive outsized moves in either direction.
The broader backdrop is structural. CMCT executed two 1-for-10 reverse stock splits in 2026 to support compliance with Nasdaq listing requirements, and it has been redeeming outstanding preferred securities by issuing common shares, a process that has expanded the share count and pressured per-share metrics. Management has also signaled efforts to strengthen liquidity, including a planned disposition of its lending business. Third-quarter results due Nov. 13 are likely to provide a fresh read on these initiatives, preferred-redemption activity, and the path of the balance sheet.
Looking ahead, the most important catalysts revolve around CMCT's financial stability and execution. The Nov. 13 earnings release will be closely watched for updates on net losses, liquidity, debt levels, and any change to the pace of preferred-stock redemptions, which directly affect the outstanding share count and per-share value. Progress on the planned sale of the lending business is another key factor, since proceeds could bolster near-term flexibility.
Investors should also monitor Nasdaq listing compliance and any further corporate actions, given the two reverse splits already completed in 2026. On the operating side, multifamily repositioning, leasing activity across the creative office portfolio, and broader commercial real estate financing conditions will influence results. Reported analyst price targets near $6.65 sit well above the current price, but coverage is thin, and the shares remain sensitive to liquidity and sentiment shifts rather than fundamentals alone. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
I find Tickeron’s AI Daily Buy/Sell Signals particularly useful when monitoring volatile names like this one. The platform lets me quickly review how automated models are interpreting recent price action and volume patterns across similar micro-cap REITs, which helps put the swings in CMCT into broader context without replacing my own fundamental review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CMCT's Aroon Indicator triggered a bullish signal on October 29, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 73 similar instances where the Aroon Indicator showed a similar pattern. In 50 of the 73 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 68%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for CMCT crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +18.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where CMCT advanced for three days, in 123 of 195 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The 10-day RSI Indicator for CMCT moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In 14 of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CMCT as a result. In 80 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CMCT turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 40 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
CMCT moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
CMCT broke above its upper Bollinger Band on October 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CMCT's P/B Ratio (0.036) is slightly lower than the industry average of (0.873). P/E Ratio (5.740) is within average values for comparable stocks, (201.021). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (0.666). CMCT's Dividend Yield (2.431) is considerably higher than the industry average of (0.163). CMCT's P/S Ratio (0.812) is slightly lower than the industry average of (2.856).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. CMCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CMCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry REITOffice